| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 |
Insmed Inc
INSM
|
BUY |
$235.00
Est. +126%
|
$104.16 | $137.70 |
Pending
|
$118.34
+13.6%
|
| May 21, 2026 |
Connect Biopharma Holdings Ltd - ADR
CNTB
|
BUY |
$4.00
Est. +73%
|
$2.31 | $2.93 |
Pending
|
$1.07
-53.7%
|
| Mar 12, 2026 |
United Therapeutics Corp
UTHR
|
BUY |
$625.00
Est. +15%
|
$541.60 | $609.35 |
Precision Hit (±3%)
|
$489.42
-9.6%
|
| Dec 16, 2025 |
Insmed Inc
INSM
|
BUY |
$230.00
Est. +17%
|
$196.85 | $205.23 |
Pending
|
$118.34
-39.9%
|
| Dec 11, 2025 |
Inhibikase Therapeutics Inc
IKT
|
BUY |
$4.00
Est. +167%
|
$1.50 | $2.61 |
Pending
|
$2.15
+43.3%
|
| Sep 10, 2025 |
United Therapeutics Corp
UTHR
|
BUY |
$525.00
Est. +32%
|
$396.50 | $609.35 |
Target Met
|
$489.42
+23.4%
|
| Nov 12, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$405.00
Est. +36%
|
$298.84 | $342.40 |
Miss
|
$406.09
+35.9%
|
| Oct 30, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$90.00
Est. +34%
|
$67.00 | $73.51 |
Miss
|
$62.21
-7.1%
|
| Jul 12, 2022 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$175.00
Est. +20%
|
$145.85 | - | - |
$246.51
+69.0%
|
| Jul 12, 2022 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$365.00
Est. +26%
|
$290.01 | - | - |
$516.34
+78.0%
|
| Jul 12, 2022 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$110.00
Est. +25%
|
$87.85 | - | - |
$62.21
-29.2%
|